Skip to main content


1. KSH adatbázisa 2004
2. Blaskó Gy.: Az atherothrombosis gyógyszeres kezelésének alapelvei. Blaskó Gy, Az atherothrombosis
Pharma Press 89-158.
3. J.R. Vane, Botting M.R.: The mechanism of action of aspirin. Thromb Res 2003;110:255-8.
4. Mitchell J.A., Warner T.D.: COX isoforms in the cardiovascular system: understanding the activities of
non-steroidal anti-inflammatory drugs. Nature 2006;5:76-86.
5. Ikeda U.: Anti-platelet drugs (aspirin, ticlopidin,etc.) Nippon Rinsho 2006 Apr;64(4):743-7.
6. Antitrombotic Trialists’ Collaboration: Collaborativ meta-analysis of randomised trials of antiplatelet
therapy for prevention of death, myocardial infarction, and stroke in high risk patients, BMJ (2002), pp.
7. Hennekens CH: Update on aspirin in the treatment and prevention of cardiovascular disease. Am J
Manag Care. 2002 Dec;8(22 Suppl):S691-700
8. Steering Commitee of the Physician’s Health Study Research Group.: Final report on the aspirin component
of the ongoing Physician’s Health Study. N Engl J Med 1989;321:129-131
9. Hansson L, Zanchetti A, Carruthers SG, et al., for the HOT study Group: Effects of intensive blood
pressure lowering and low-dose aspirin in patients with hypertension: principle results of the Hypertension
Optimal Treatement (HOT) randomized trial. Lancet 1998;351:1755-1762
10. Lewis HD Jr, Davis JW, Archibald DG, et al: Protective effects of aspirin against acut myocardial
infarctus and death in men with unsatable angina. Results of a Veterans Administartion Cooperative
Study. N Engl J Med. 1983;309:396-403
11. Baigent C, Collins R, Appleby P, Parish S, Sleight P, Peto R ISIS-2: 10 year survival among patients
with suspected acute myocardial infarction in randomised comparison of intravenous streptokinase,
oral aspirin, both, or neither. BMJ.1998 May 2;316(7141):1337-43.
12. Keller TT, Squizzato A, Middeldorp S.: Clopidogrel plus aspirin versus aspirin alone for preventing
cardiovascular disease. Cochrane Database of Systematic Reviews 2007, Issue 3. Art. No.: CD005158. DOI: